Literature DB >> 28666844

Esculentoside A inhibits LPS-induced acute kidney injury by activating PPAR-γ.

De-Zhun Chen1, Li-Qiong Chen1, Meng-Xiang Lin1, Yu-Qiang Gong1, Bin-Yu Ying1, Da-Zhen Wei2.   

Abstract

Acute kidney injury (AKI) is a major clinical problem associated with high morbidity and mortality. Esculentoside A (EsA), a kind of saponin isolated from the root of the Chinese herb Phytolaca esculenta, has been reported to have anti-inflammatory effect. In this study, we aimed to investigate the protective effects of EsA on LPS-induced AKI in mice. The protective effects of EsA was evaluated by detecting kidney histological change, blood urea nitrogen (BUN) and creatinine levels, and inflammatory cytokines production. The results showed that EsA significantly attenuated LPS-induced kidney histological change, as well as BUN and creatinine levels. EsA also inhibited LPS-induced TNF-α, IL-1β, and IL-6 production. LPS-induced NF-κB activation was significantly suppressed by treatment of EsA. In addition, EsA up-regulated the expression of PPAR-γ in a dose-dependent manner. In conclusion, EsA protected mice effectively from LPS-induced AKI by PPAR-γ, which subsequently inhibited LPS-induced inflammatory response.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Esculentoside A; LPS; NF-κB; PPAR-γ

Mesh:

Substances:

Year:  2017        PMID: 28666844     DOI: 10.1016/j.micpath.2017.06.037

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  5 in total

Review 1.  Nitrolipids in kidney physiology and disease.

Authors:  Soma Jobbagy; Roderick J Tan
Journal:  Nitric Oxide       Date:  2018-03-29       Impact factor: 4.427

2.  Tofacitinib Ameliorates Lipopolysaccharide-Induced Acute Kidney Injury by Blocking the JAK-STAT1/STAT3 Signaling Pathway.

Authors:  Yang Yun; Jingyu Chen; Xuejiao Wang; Yingzhuo Li; Zhifan Hu; Pingting Yang; Ling Qin
Journal:  Biomed Res Int       Date:  2021-01-13       Impact factor: 3.411

3.  Esculentoside A could attenuate apoptosis and inflammation in TNBS-induced ulcerative colitis via inhibiting the nuclear translocation of NF-κB.

Authors:  Ying Liu; Wenhua Wei; Shiwei Liang; Haicheng Fang; Jie Cao
Journal:  Ann Transl Med       Date:  2022-07

4.  Esculentoside A Alleviates Intestinal Dysmotility in Ulcerative Colitis by Regulating H2S/CSE and NO/nNOS Systems.

Authors:  Ying Liu; Wenhua Wei; Shiwei Liang; Haicheng Fang; Jie Cao
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-31       Impact factor: 2.650

Review 5.  Application of Herbal Traditional Chinese Medicine in the Treatment of Acute Kidney Injury.

Authors:  Hai-Di Li; Xiao-Ming Meng; Cheng Huang; Lei Zhang; Xiong-Wen Lv; Jun Li
Journal:  Front Pharmacol       Date:  2019-04-18       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.